Cambridge, United Kingdom

Christopher Cozens

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christopher Cozens: Innovator in Nucleic Acid Polymerase Technology

Introduction

Christopher Cozens is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid polymerases. With a total of 2 patents to his name, Cozens has focused on innovations that enhance the capabilities of polymerases in various applications.

Latest Patents

Cozens' latest patents revolve around enzymes that are capable of producing non-DNA nucleotide polymers from DNA nucleotide templates. One of his inventions describes a nucleic acid polymerase that includes an amino acid sequence with at least 36% identity to a specific sequence, SEQ ID NO:1. This polymerase is characterized by mutations in the thumb region, particularly at residues E664, Y409G, and E664K. Another aspect of his work involves a polymerase that can reverse transcribe HNA nucleotide polymers into DNA nucleotide polymers, showcasing the versatility and potential applications of his inventions.

Career Highlights

Throughout his career, Christopher Cozens has worked with esteemed organizations such as the Medical Research Council and United Kingdom Research and Innovation. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Cozens has collaborated with prominent scientists in his field, including Philipp Holliger and Vitor B Pinheiro. These collaborations have further enriched his research and have led to innovative advancements in nucleic acid technology.

Conclusion

Christopher Cozens is a distinguished inventor whose work in nucleic acid polymerases has the potential to impact various scientific fields. His patents reflect a commitment to innovation and excellence in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…